Kerry received a B.S. in Chemical Engineering from the University of Kansas in 2019 and is a current Ph.D. student in the Regnier Lab. Her research utilizes engineered hiPSC lines to investigate the role of MYH7 mutations in causing dilated and hypertrophic cardiomyopathy at the cellular and sub-cellular levels. When she is not in the lab, Kerry enjoys baking for her friends and roommates, running along Lake Union, and playing piano.